{
    "nctId": "NCT06002022",
    "briefTitle": "Evaluation of Improvements in Patient-reported Quality of Life",
    "officialTitle": "Local Intervention Trial for the Evaluation of Improvements in Patient-reported Quality of Life and Treatment Satisfaction in BCP as a Result of Flexible Treatment Planning Supported by REBECCA-collected RWD",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Quality of Life, Physical Activity, Sleep Quality, Stress, Pain",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 110,
    "primaryOutcomeMeasure": "Resting quality",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Before patient registration, written informed consent must be given according to national and local regulations.\n* Participants have had histologically proven stage I-III breast cancer undergoing endocrine treatment (with or without prior chemotherapy) no more than 12 months prior to randomization.\n* Be between 18 and 75 years of age.\n* Have increased life expectancy beyond the initial 3 months post-treatment initiation.\n* Have the ability to understand protocol, participate in testing and willingness to sign a written informed consent.\n* Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.\n\nExclusion Criteria:\n\n* Patients that are not willing to sign an informed consent form",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}